Sunshine Biopharma, Inc. (SBFM)

0.4175 -0.0224 (-5.09%) 收市：04:00PM EDT

Sunshine Biopharma, Inc.

1177 Avenue of the Americas
5th floor
New York, NY 10036
United States
332 216 1147
https://sunshinebiopharma.com

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 44

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Steve N. Slilaty Ph.D.	CEO, President & Chairman	640k	無	1952
Mr. Camille Sebaaly	CFO & Secretary	695k	無	1959
Dr. Abderrazzak Merzouki	Chief Science Officer & Director	340k	無	1964
Mr. Marc Beaudoin	Chief Operating Officer	無	無	1967
Mr. Malek Chamoun	Chief Development Officer	無	無	1985
Mr. Robert G. Ferreira	President of Sunshine Bio Investments Inc	無	無	1962

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is headquartered in New York, New York.

公司管治

截至 無 止，Sunshine Biopharma, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。